@article {Narita204, author = {Naohiro Narita and Akio Morohashi and Kimio Tohyama and Toshiyuki Takeuchi and Yoshihiko Tagawa and Takahiro Kondo and Satoru Asahi}, title = {Mechanism for Covalent Binding of MLN3126, an Oral Chemokine C-C Motif Receptor 9 Antagonist, to Serum Albumins}, volume = {46}, number = {3}, pages = {204--213}, year = {2018}, doi = {10.1124/dmd.117.078782}, publisher = {American Society for Pharmacology and Experimental Therapeutics}, abstract = {N-{4-Chloro-2-[(1-oxidopyridin-4-yl)carbonyl]phenyl}-4-(propan-2-yloxy)benzenesulfonamide (MLN3126) is an orally available chemokine C-C motif receptor 9 selective antagonist. In nonclinical pharmacokinetic studies of MLN3126, nonextractable radioactivity was observed in plasma after oral administration of 14C-labeled MLN3126 ([14C]MLN3126) to Sprague-Dawley (SD) rats. In this study, the nonextractable radioactive component was digested with trypsin or a nonspecific protease, pronase, after chemical reduction to obtain drug-peptide adducts or drug-amino acid adducts. The chemical structure of these adducts was characterized by liquid chromatography/mass spectrometry. The results demonstrated that the major part of the nonextractable radioactivity was accounted for by covalent binding via the Schiff base formed specifically between the ε-amino group of lysine residue 199 in rat serum albumin and the carbonyl group of MLN3126. The half-life (t1/2) of the total radioactivity in plasma during and after 21 daily multiple oral administrations of [14C]MLN3126 to SD rats was approximately 5-fold shorter than the reported t1/2 of albumin in rats. The data indicated that the covalent binding was reversible under physiologic conditions. The formation of the covalent binding was also confirmed in in vitro incubations with serum albumins from rats, humans, and dogs in the same manner, indicating that there are no qualitative interspecies differences in the formation of the Schiff base.}, issn = {0090-9556}, URL = {https://dmd.aspetjournals.org/content/46/3/204}, eprint = {https://dmd.aspetjournals.org/content/46/3/204.full.pdf}, journal = {Drug Metabolism and Disposition} }